Jerman

Index
Globenewswire

Mavenir Menjadi Vendor Perangkat Lunak Jaringan Besar Pertama yang Menerima Sertifikasi Fungsi Jaringan 5G Packet Core dalam Skema BSI NESAS Jerman

Globenewswire

Mavenir First Major Network Software Vendor to Receive 5G Packet Core Network Function Certification Under Germany's BSI NESAS Scheme

Globenewswire

Boehringer Ingelheim’s survodutide Phase III trial showed targeted 34% visceral and 63% liver fat reduction, while minimizing lean mass loss in pre-specified analysis, supporting improved metabolic health in people living with obesity

Globenewswire

GetYourGuide unveils summer 2026's three defining travel trends

Globenewswire

AGC Biologics to Manufacture Teikoku Seiyaku's rhMMP-7 Drug Substance

Globenewswire

CHMP issues positive opinion for JASCAYD® (nerandomilast), bringing a new IPF and PPF therapy closer to patients in the EU

Globenewswire

China approves HERNEXEOS® as first targeted oral treatment option for HER2-mutant advanced NSCLC at initial diagnosis

Globenewswire

Boehringer Ingelheim’s oncology portfolio shows strong promise across multiple cancers at ASCO 2026

Globenewswire

EIF commits EUR 200 million to Copenhagen Infrastructure Partners to scale European biogas production

Globenewswire

ATOSS Opens AI Technology Hub in Bengaluru to Drive AI-Powered Workforce Management Solutions

Globenewswire

Boehringer Ingelheim licenses preclinical antibody program from Immunitas Therapeutics to advance treatments for chronic inflammatory diseases

Globenewswire

BASF Agricultural Solutions successfully commissions new fermentation plant for crop protection products in Ludwigshafen

Globenewswire

The Retail Marketeers and PDI Technologies Announce Recipients of the 2026 European Female Leaders in Convenience Awards

Globenewswire

Dr. Falk Pharma and Renexxion announce positive results on naronapride in gastroparesis from the global phase 2b MOVE-IT trial

Globenewswire

Boehringer Ingelheim and Eko Health Inc. launch new AI-based solution that detects heart murmurs in dogs

Globenewswire

Boehringer Ingelheim’s novel glucagon/GLP-1 dual agonist survodutide achieved significant weight loss of 16.6% delivering meaningful metabolic improvement in people with obesity or overweight in Phase III trial

Globenewswire

Every minute counts: EAACI calls for urgent action to make schools safe for children at risk of anaphylaxis

Globenewswire

The Rise of “Grandma Tourism:” Why almost 70% of travelers prefer learning from older locals when on holiday

Globenewswire

Boehringer Ingelheim expands investment in computational innovation with new AI Accelerator in UK’s Knowledge Quarter

Globenewswire

Schneider Electric and Deloitte collaborate to drive AI-enabled digital transformation across industrial operations

Globenewswire

Challenge accepted: Schneider Electric helps industry turn toughest problems into competitive advantage

Globenewswire

Schneider Electric unveils next generation agentic manufacturing capabilities powered by Microsoft Azure AI at Hannover Messe 2026

Globenewswire

Beamion LUNG-1 study results for zongertinib in treatment-naïve patients with HER2-mutant advanced NSCLC published in The New England Journal of Medicine

Globenewswire

Boehringer Ingelheim and Zai Lab announce Collaboration on DLL3‑targeting T‑Cell Engager and ADC Combination in Small Cell Lung Cancer and Other Neuroendocrine Carcinomas

Globenewswire

Nemetschek Group to Acquire HCSS; Creates Next Global Construction Technology Leader